Literature DB >> 19207724

Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.

Jeffrey E Quigley1, Ahmed A Elmarakby, Sarah F Knight, Marlina M Manhiani, David W Stepp, Jeffrey J Olearzcyk, John D Imig.   

Abstract

1. In the present study, we determined the role of hypertension, oxidative stress and inflammation on kidney damage in a rodent model of obesity and diabetes. Hypertension was induced in male obese (db/db) mice and lean (db/m) mice by implantation of deoxycorticosterone acetate (DOCA) pellets and mice were allowed to drink water containing 1% salt. Mice were divided into six groups as follows: obese and lean control, obese and lean 1% salt (salt) and obese and lean DOCA plus 1% salt (DOCA-salt). 2. Blood pressure was significantly increased in lean and obese DOCA-salt groups relative to their respective controls; however, there was no difference in blood pressure between the lean and obese control and salt groups. Urinary 8-isoprostane was increased in obese control compared with lean control mice (1464 +/- 267 vs 493 +/- 53 pg/micromol creatinine, respectively) and this elevation was further increased in the obese DOCA-salt treated mice (2430 +/- 312 pg/micromol creatinine). Urinary monocyte chemoattractant protein-1 excretion and CD68-positive cells were also increased in both obese and lean DOCA-salt groups compared with their respective controls. Furthermore, DOCA-salt treatment increased collagen IV excretion in both obese and lean mice compared with controls, but there was no difference between obese and lean DOCA-salt groups. Urinary albumin excretion was significantly increased in the obese compared with the lean DOCA-salt mice (507 +/- 160 vs 202 +/- 48 microg/day, respectively). 3. These data suggest that obese DOCA-salt hypertensive mice exhibit greater renal injury than lean DOCA-salt hypertensive mice in a manner independent of blood pressure and that this renal injury is associated with obesity related pre-existing renal oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207724      PMCID: PMC2710419          DOI: 10.1111/j.1440-1681.2009.05139.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  22 in total

1.  Receptor-mediated regional sympathetic nerve activation by leptin.

Authors:  W G Haynes; D A Morgan; S A Walsh; A L Mark; W I Sivitz
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

2.  Role of leptin in fat regulation.

Authors:  S Collins; C M Kuhn; A E Petro; A G Swick; B A Chrunyk; R S Surwit
Journal:  Nature       Date:  1996-04-25       Impact factor: 49.962

3.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

4.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Authors:  D Koya; M Haneda; H Nakagawa; K Isshiki; H Sato; S Maeda; T Sugimoto; H Yasuda; A Kashiwagi; D K Ways; G L King; R Kikkawa
Journal:  FASEB J       Date:  2000-03       Impact factor: 5.191

5.  TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.

Authors:  Ahmed A Elmarakby; Jeffrey E Quigley; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

6.  Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Ahmed A Elmarakby; Peter Morsing; Jennifer S Pollock; David M Pollock
Journal:  Vascul Pharmacol       Date:  2003-12       Impact factor: 5.773

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Predictors of new-onset kidney disease in a community-based population.

Authors:  Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

9.  Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide.

Authors:  Satoshi Kumano; Hirokazu Matsumoto; Yoshihiro Takatsu; Jiro Noguchi; Chieko Kitada; Tetsuya Ohtaki
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

Review 10.  Obesity and hypertension: two epidemics or one?

Authors:  Kevin P Davy; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-05       Impact factor: 3.619

View more
  9 in total

1.  Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism.

Authors:  Kristin E Claflin; Jeremy A Sandgren; Allyn M Lambertz; Benjamin J Weidemann; Nicole K Littlejohn; Colin M L Burnett; Nicole A Pearson; Donald A Morgan; Katherine N Gibson-Corley; Kamal Rahmouni; Justin L Grobe
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

Review 2.  Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.

Authors:  Jonathan M Nizar; Vivek Bhalla
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

3.  Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.

Authors:  Ahmed A Elmarakby; John D Imig
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

4.  Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin.

Authors:  Alessandra Stacchiotti; Gaia Favero; Lorena Giugno; Antonio Lavazza; Russel J Reiter; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 5.  Role of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An Update.

Authors:  Cheng Wan; Hua Su; Chun Zhang
Journal:  Oxid Med Cell Longev       Date:  2016-08-15       Impact factor: 6.543

6.  Protective Effect of Edaravone Against Oxidative Stress in C2C12 Myoblast and Impairment of Skeletal Muscle Regeneration Exposed to Ischemic Injury in Ob/ob Mice.

Authors:  Takuya Nakanishi; Masaya Tsujii; Takahiro Asano; Takahiro Iino; Akihiro Sudo
Journal:  Front Physiol       Date:  2020-01-15       Impact factor: 4.566

7.  Inflammation and oxidative stress in obesity-related glomerulopathy.

Authors:  Jinhua Tang; Haidong Yan; Shougang Zhuang
Journal:  Int J Nephrol       Date:  2012-04-05

8.  DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.

Authors:  Ravi Nistala; Javad Habibi; Annayya Aroor; James R Sowers; Melvin R Hayden; Alex Meuth; William Knight; Tamara Hancock; Thomas Klein; Vincent G DeMarco; Adam Whaley-Connell
Journal:  Obesity (Silver Spring)       Date:  2014-07-04       Impact factor: 5.002

9.  Renal Protective Effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) in Obese Rats on a High-Salt Diet.

Authors:  Mani Maheshwari; Cesar A Romero; Sumit R Monu; Nitin Kumar; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Hypertens       Date:  2018-07-16       Impact factor: 2.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.